# E-DRUG: drug interaction database

**URL:** <https://talk.edrugplus.org/t/e-drug-drug-interaction-database/947>\
**Category:** e-drug\
**Created:** [June 10, 1997, 9:20pm UTC](https://talk.edrugplus.org/t/e-drug-drug-interaction-database/947 "1997-06-10T21:20:37Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Sinikka\_Sihvo1](https://avatars.discourse-cdn.com/v4/letter/s/3ec8ea/32.png) [@Sinikka\_Sihvo1](https://talk.edrugplus.org/u/Sinikka_Sihvo1)\
**Post date:** [June 10, 1997, 9:20pm UTC](https://talk.edrugplus.org/t/e-drug-drug-interaction-database/947/1 "1997-06-10T21:20:37Z")

</div>

Dear listmembers,

Does anyone have knowledge about solfware drug interaction programs where  
ALL the possible interactions of certain drugs are included and classified  
according to their clinical relevance? (I am not talking about ADRs which  
are based on volontary reports)

I would need this kind of database for the analysis of drug interactions  
from a population based health interview data. I am especailly interested in  
interactions where OTC drugs are involved.

All information would be greatly appreciated.

Best regards, Sinikka Sihvo  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B.Sc(Pharn), MPH  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stakes (National Research and Development Centre for Welfare  
and Health), Health Services Research Unit  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;P.O.Box 220, 00531 Helsinki, Finland  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\<sinikka.sihvo@stakes.fi\>  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;fax +358 9 3967 2485

--  
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.  
Mail administrative requests to `majordomo@usa.healthnet.org'.  
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.
